System-level factors shaping the implementation of “hub and spoke” systems to expand MOUD in rural areas

References

• Center for Behavioral Health Statistics and Quality. Results from the 2015 National Survey on Drug Use and Health: Detailed Tables Prevalence Estimates, Standard Errors, p Values, and Sample Sizes. Rockville, MD; 2016. https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015.pdf. Accessed January 26, 2018.
   Google Scholar
• Borders TF. Portraying a more complete picture of illicit drug use epidemiology and policy for rural america: a competing viewpoint to the CDC’s MMWR report. J Rural Health. 2018;34(1):3–5.
   PubMed Web of Science ®Google Scholar
• Brown JD, Goodin AJ, Talbert JC. Rural and appalachian disparities in neonatal abstinence syndrome incidence and access to opioid abuse treatment. J Rural Heal. 2018;34(1):6–13.
   PubMed Web of Science ®Google Scholar
• Pullen E, Oser C. Barriers to substance abuse treatment in rural and urban communities: counselor perspectives. Subst Use Misuse. 2014;49(7):891–901.
   PubMed Web of Science ®Google Scholar
• Knudsen HK, Johnson JA, Roman PM, Oser CB. Rural and urban similarities and differences in private substance abuse treatment centers. J Psychoactive Drugs. 2003;35(4):511–518.
   PubMed Web of Science ®Google Scholar
• Oser CB, Leukefeld CG, Staton Tindall M, et al. Rural drug users: factors associated with substance abuse treatment utilization. Int J Offender Ther Comp Criminol. 2011;55(4):567–586.
   PubMed Web of Science ®Google Scholar
• Dick AW, Pacula RL, Gordon AJ, et al. Growth in buprenorphine waivers for physicians increased potential access to opioid agonist treatment, 2002–11. Health Aff. 2015;34(6):1028–1034.
   PubMed Web of Science ®Google Scholar
• DeFlavio JR, Rolin SA, Nordstrom BR, Kazal LA. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians. Rural Remote Health. 2015;15:3019.
   PubMed Web of Science ®Google Scholar
• Brooklyn JR, Sigmon SC. Vermont hub-and-spoke model of care for opioid use disorder: development, implementation, and impact. J Addict Med. 2017;11(4):286–292.
   PubMed Web of Science ®Google Scholar
• Sigmon SC. Access to treatment for opioid dependence in rural america: challenges and future directions. JAMA Psychiatry. 2014;71(4):359–360.
   PubMed Web of Science ®Google Scholar
• Simpatico TA. Vermont responds to its opioid crisis. Prev Med. 2015;80:10–11.
   PubMed Web of Science ®Google Scholar
• Rawson R. Vermont Hub-and-Spoke Model of Care for Opioid use Disorders: An Evaluation. Burlington, VT: Vermont Center on Behavior & Health; 2017.
   Google Scholar
• Rawson R, Cousins SJ, McCann M, Pearce R, Van Donsel A. Assessment of medication for opioid use disorder as delivered within the Vermont hub and spoke system. J Subst Abuse Treat. 2019;97:84–90.
   PubMed Web of Science ®Google Scholar
• Winstanley EL, Lander LR, Berry JH, et al. West Virginia’s model of buprenorphine expansion: preliminary results. J Subst Abuse Treat. 108:40–47.
   PubMed Web of Science ®Google Scholar
• Reif S, Brolin MF, Stewart MT, Fuchs TJ, Speaker E, Mazel SB. The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders. J Subst Abuse Treat. 108:33–39.
   PubMed Web of Science ®Google Scholar
• Darfler K, Urada D, Antonini V, Padwa H, Joshi V, Sandoval J. California Hub and Spoke Medication Assisted Treatment Expansion Program: Year 1 Evaluation Report. Sacramento: University of California Los Angeles Integrated Substance Abuse Programs; 2018.
   Google Scholar
• Miele GM, Caton L, Freese TE, et al. Implementation of the hub and spoke model for opioid use disorders in California: rationale, design and anticipated impact. J Subst Abuse Treat. 2020;108:20–25. doi:https://doi.org/10.1016/j.jsat.2019.07.013
   PubMed Web of Science ®Google Scholar
• Urada D, Padwa H. Evaluation of California’s hub and spoke system. In: CA Hub & Spoke System Steering Committee. Sacramento, CA: The California Hub and Spoke System; 2016.
   Google Scholar
• Services CD of HC. TI-17-014 MAT Expansion Project for State-Targeted Response to Opioid Epidemic. 2016.
   Google Scholar
• Willging CE, Aarons GA, Trott EM, et al. Contracting and procurement for evidence-based interventions in public-sector human services: a case study. Adm Policy Ment Health. 2016;43(5):675–692.
   PubMed Web of Science ®Google Scholar
• Willging CE, Sommerfeld DH, Aarons GA, Waitzkin H. The effects of behavioral health reform on safety-net institutions: a mixed-method assessment in a rural state. Adm Policy Ment Health. 2014;41(2):276–291.
   PubMed Web of Science ®Google Scholar
• Yin RK. Case Study Research: Design and Methods. 4th ed. Thousand Oaks, CA: Sage Publications; 2009.
   Google Scholar
• Aarons GA, Hurlburt M, Horwitz SM. Advancing a conceptual model of evidence-based practice implementation in public service sectors. Adm Policy Ment Health. 2011;38(1):4–23.
   PubMed Web of Science ®Google Scholar
• Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–357.
   PubMed Web of Science ®Google Scholar
• Parker T. Rural-Urban Continuum Codes – Documentation. United States Department of Agriculture, Economic Research Service. https://www.ers.usda.gov/data-products/rural-urban-continuum-codes/documentation/. Published 2013. Accessed November 05, 2020.
   Google Scholar
• California Department of Public Health. California Opioid Overdose Surveillance Dashboard. https://pdop.shinyapps.io/ODdash_v1/. Published 2017. Accessed January 29, 2018.
   Google Scholar
• Palinkas LA, Aarons GA, Horwitz S, Chamberlain P, Hurlburt M, Landsverk J. Mixed method designs in implementation research. Adm Policy Ment Health. 2011;38(1):44–53.
   PubMed Web of Science ®Google Scholar
• Dedoose Version 7.0.23. 2016.
   Google Scholar
• Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. doi:https://doi.org/10.1191/1478088706qp063oa
   Google Scholar
• Max A, Garrow R, Willis M. Tackling an Epidemic: An Assessment of the California Opioid Safety Coalitions Network. Oakland: Public Health Institute; 2017.
   Google Scholar
• Kravitz-Wirtz N, Davis CS, Ponicki WR, et al. Association of medicaid expansion with opioid overdose mortality in the United States. JAMA Netw Open. 2020;3(1):e1919066.
   PubMed Web of Science ®Google Scholar
• Wen H, Hockenberry JM, Borders TF, Druss BG. Impact of medicaid expansion on medicaid-covered utilization of buprenorphine for opioid use disorder treatment. Med Care. 2017;55(4):336–341.
   PubMed Web of Science ®Google Scholar
• Andrilla CHA, Coulthard C, Larson EH. Barriers rural physicians face prescribing buprenorphine for opioid use disorder. Ann Fam Med. 2017;15(4):359–362. doi:https://doi.org/10.1370/afm.2099
   PubMed Web of Science ®Google Scholar
• Cloud DH, Ibragimov U, Prood N, Young AM, Cooper HLF. Rural risk environments for hepatitis c among young adults in appalachian kentucky. Int J Drug Policy. 2019;72:47–54.
   PubMed Web of Science ®Google Scholar
• Thomas N, van de Ven K, Mulrooney KJD. The impact of rurality on opioid-related harms: a systematic review of qualitative research. Int J Drug Policy. 2019:102607. doi:https://doi.org/10.1016/j.drugpo.2019.11.015
   Google Scholar
• Syvertsen JL, Pollini RA. Syringe access and health harms: characterizing “landscapes of antagonism” in California’s Central Valley. Int J Drug Policy. 2020;75:102594.
   PubMed Web of Science ®Google Scholar
• Winograd RP, Wood CA, Stringfellow EJ, et al. Implementation and evaluation of Missouri’s medication first treatment approach for opioid use disorder in publicly-funded substance use treatment programs. J Subst Abuse Treat. 2019;0(0):15.
   Google Scholar
• Martin SA, Chiodo LM, Bosse JD, Wilson A. The next stage of buprenorphine care for opioid use disorder. Ann Intern Med. 2018;169(9):628. doi:https://doi.org/10.7326/M18-1652
   PubMed Web of Science ®Google Scholar
• Allen ST, Grieb SM, O’Rourke A, et al. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs. Harm Reduct J. 2019;16(1):33.
   PubMed Web of Science ®Google Scholar
• Schranz AJ, Barrett J, Hurt CB, Malvestutto C, Miller WC. Challenges facing a rural opioid epidemic: treatment and prevention of HIV and hepatitis C. Curr HIV/AIDS Rep. 2018;15(3):245–254.
   PubMed Web of Science ®Google Scholar
• Pollini RA. Wild … but not so wonderful-responding to injection drug use in West Virginia . Am J Public Health. 2019;109(3):354–355.
   PubMed Web of Science ®Google Scholar
• Yin RK. Case Study Research: Design and Methods. Thousand Oaks: Sage Publications; 2009.
   Google Scholar
• Parker T. Rural-Urban Continuum Codes – Documentation. United States Department of Agriculture, Economic Research Service 2013. https://www.ers.usda.gov/data-products/rural-urban-continuum-codes/documentation/. Accessed November 05, 2020.
   Google Scholar
• California Department of Public Health. California Opioid Overdose Surveillance Dashboard. 2017. https://pdop.shinyapps.io/ODdash_v1/. Accessed January 39, 2018)
   Google Scholar
• Health Care Foundation, C. California’s Rural Health Clinics: Obstacles and Opportunities. 2012.
   Google Scholar
• Mohatt DF, Bradley MM, Adams SJ, Morris CD. Mental Health and Rural America: 1994–2005. 2005.
   Google Scholar